BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

176 related articles for article (PubMed ID: 6685580)

  • 1. Combination chemotherapy including adriamycin for advanced transitional cell carcinoma of the urinary tract.
    Kotake T; Usami M; Miki T; Kuroda M; Obata K; Osafune M; Fujioka H; Takasugi Y
    Cancer Chemother Pharmacol; 1983; 11 Suppl():S38-42. PubMed ID: 6685580
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Results of adjuvant chemotherapy for invasive urothelial cancer with lymph-node metastasis.
    Kobayashi H; Obata K
    Cancer Chemother Pharmacol; 1994; 35 Suppl():S14-7. PubMed ID: 7994781
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Phase III trial of the Japanese Urological Cancer Research Group for Adriamycin: cyclophosphamide, adriamycin and cisplatinum versus cyclophosphamide, adriamycin and 5-fluorouracil in patients with advanced transitional cell carcinoma of the urinary bladder.
    Maru A; Akaza H; Isaka S; Koiso K; Kotake T; Machida T; Matsumura Y; Nakagami Y; Niijima T; Obata K
    Cancer Chemother Pharmacol; 1987; 20 Suppl():S44-8. PubMed ID: 3311445
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Combination chemotherapy of advanced transitional cell carcinoma with cis-platinum, cyclophosphamide, adriamycin and 5-fluorouracil (CISCAF)].
    Fujioka H; Tada Y; Nakano E; Matsuda M; Osafune M; Sagawa S; Takaha M; Sonoda T
    Gan To Kagaku Ryoho; 1984 Aug; 11(8):1612-6. PubMed ID: 6541019
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Combination chemotherapy of advanced bladder cancer].
    Kiyohara H
    Hinyokika Kiyo; 1986 Dec; 32(12):1925-30. PubMed ID: 3825829
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Combination chemotherapy with methotrexate (MTX), vincristine (VCR), cisplatinum (CDDP), cyclophosphamide (CPM), adriamycin (ADM), and bleomycin (BLM); MVP-CAB in patients with advanced urothelial tract cancer].
    Fujii A; Morishita S; Nakamura I; Oka Y; Ohshima H; Nagata H; Iwamoto T; Izumi T; Miyasaki Z; Ito N
    Nihon Hinyokika Gakkai Zasshi; 1988 Jun; 79(6):985-93. PubMed ID: 2460657
    [No Abstract]   [Full Text] [Related]  

  • 7. A study of cyclophosphamide, adriamycin, cis-platinum, and methotrexate in advanced transitional cell carcinoma of the urinary tract.
    Citrin DL; Hogan TF; Davis TE
    Cancer; 1983 Jan; 51(1):1-4. PubMed ID: 6681590
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Comparative activity and toxicity of cis-diamminedichloroplatinum (DDP) and a combination of doxorubicin, cyclophosphamide, and DDP in disseminated transitional cell carcinomas of the urinary tract.
    Khandekar JD; Elson PJ; DeWys WD; Slayton RE; Harris DT
    J Clin Oncol; 1985 Apr; 3(4):539-45. PubMed ID: 3884746
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The effect of dose intensity on M-VAC therapy for advanced urothelial cancer.
    Miyanaga N; Akaza H; Shimazui T; Ohtani M; Koiso K
    Cancer Chemother Pharmacol; 1994; 35 Suppl():S5-8. PubMed ID: 7527735
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Methotrexate, vinblastine, doxorubicin, and cisplatin for advanced transitional cell carcinoma of the urothelium. Efficacy and patterns of response and relapse.
    Sternberg CN; Yagoda A; Scher HI; Watson RC; Geller N; Herr HW; Morse MJ; Sogani PC; Vaughan ED; Bander N
    Cancer; 1989 Dec; 64(12):2448-58. PubMed ID: 2819654
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Combination chemotherapy for advanced urothelial-tract carcinoma.
    Sahashi M; Ono Y; Matsuura O; Ohshima S; Fukushima M
    Cancer Chemother Pharmacol; 1992; 30 Suppl():S59-62. PubMed ID: 1394820
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Three-drug combination chemotherapy for advanced urothelial tract carcinoma.
    Ohshima S; Ono Y; Fujita T; Aso Y
    Cancer Chemother Pharmacol; 1987; 20 Suppl():S20-3. PubMed ID: 2444354
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Combination chemotherapy with fluorouracil, adriamycin, cis-platinum and VM-26 in advanced transitional cell carcinoma of the urinary tract.
    Veronesi A; Galligioni E; Lo Re G; Sorio R; Saracchini S; Francini M; Merlo A; Dal Bo V; Monfardini S
    Eur J Cancer Clin Oncol; 1986 Dec; 22(12):1457-60. PubMed ID: 3595670
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Postoperative systemic adjuvant chemotherapy for bladder cancer.
    Kiyohara H; Kuroda M; Saiki S; Miki T; Kinouchi T; Usami M; Kotake T
    Cancer Chemother Pharmacol; 1987; 20 Suppl():S34-8. PubMed ID: 3664942
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Polychemotherapy treatment with cisplatin, adriamycin, 5-fluorouracil (FAP) and cisplatin, adriamycin and cyclophosphamide (CISCA) in advanced transitional carcinoma of the bladder].
    Sánchez Romero JA; Ramírez Ruiz F; Romero Fernández L; Pastor Gaitán P; Murillo Capitán E
    Actas Urol Esp; 1989; 13(4):240-2. PubMed ID: 2678934
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Combination chemotherapy for advanced bladder cancer with adriamycin, cyclophosphamide, and 5-fluorouracil.
    Tashiro K; Machida T; Masuda F; Ohishi Y
    Cancer Chemother Pharmacol; 1983; 11 Suppl():S43-6. PubMed ID: 6640834
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Preliminary results of M-VAC (methotrexate, vinblastine, doxorubicin and cisplatin) for transitional cell carcinoma of the urothelium.
    Sternberg CN; Yagoda A; Scher HI; Watson RC; Ahmed T; Weiselberg LR; Geller N; Hollander PS; Herr HW; Sogani PC
    J Urol; 1985 Mar; 133(3):403-7. PubMed ID: 4038749
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Adjuvant chemotherapy with MVP-CAB (methotrexate, vincristine, cisplatinum, cyclophosphamide, adriamycin and bleomycin) for epithelial tumors of the upper urinary tract].
    Fujii A; Oka N; Murata Y; Higuchi A; Itoh N; Ishikawa J; Tanaka H
    Nihon Hinyokika Gakkai Zasshi; 1992 Oct; 83(10):1609-14. PubMed ID: 1279258
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Combination chemotherapy with cisplatin, ifosfamide and adriamycin in patients with advanced transitional cell carcinoma of the urinary tract].
    Yoshimoto J; Nasu Y; Akagi T; Obama T; Tsushima T; Ozaki Y; Matsumura Y; Ohmori H; Asahi T; Ohkita K
    Gan To Kagaku Ryoho; 1985 Jun; 12(6):1312-7. PubMed ID: 4039919
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Phase II trial cisplatin, doxorubicin, and cyclophosphamide (CAP) in the treatment of urothelial transitional cell carcinoma.
    Campbell M; Baker LH; Opipari M; Al-Sarraf M
    Cancer Treat Rep; 1981; 65(9-10):897-9. PubMed ID: 7196800
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.